These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 19901200)
1. Letter by Brown and Pretorius regarding article, "effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients". Brown NJ; Pretorius M Circulation; 2009 Nov; 120(19):e159; author reply e160. PubMed ID: 19901200 [No Abstract] [Full Text] [Related]
2. Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients. Giannarelli C; Virdis A; De Negri F; Magagna A; Duranti E; Salvetti A; Taddei S Circulation; 2009 Mar; 119(12):1625-33. PubMed ID: 19289643 [TBL] [Abstract][Full Text] [Related]
7. Effect of endothelin on the release of tissue plasminogen activator and plasminogen activator inhibitor-1 from cultured human endothelial cells and interaction with thrombin. Yamamoto C; Kaji T; Sakamoto M; Koizumi F Thromb Res; 1992 Sep; 67(5):619-24. PubMed ID: 1448794 [No Abstract] [Full Text] [Related]
8. Modulation by endothelin-1 of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells: interaction of endothelin-1 with cytokines. Yamamoto C; Kaji T; Sakamoto M; Kozuka H Biol Pharm Bull; 1993 Jul; 16(7):714-5. PubMed ID: 8401409 [TBL] [Abstract][Full Text] [Related]
9. Tissue-type plasminogen activator release in healthy subjects and hypertensive patients: relationship with beta-adrenergic receptors and the nitric oxide pathway. Giannarelli C; Virdis A; De Negri F; Duranti E; Magagna A; Ghiadoni L; Salvetti A; Taddei S Hypertension; 2008 Aug; 52(2):314-21. PubMed ID: 18574075 [TBL] [Abstract][Full Text] [Related]
11. Tissue-type plasminogen activator release: new frontiers in endothelial function. Muldowney JA; Vaughan DE J Am Coll Cardiol; 2002 Sep; 40(5):967-9. PubMed ID: 12225724 [No Abstract] [Full Text] [Related]
12. Release of tissue plasminogen activator during coronary angioplasty. Weyne A; de Buyzere M; Clement D; Baele G; Leroux-Roels G Lancet; 1990 Mar; 335(8690):658. PubMed ID: 1969029 [No Abstract] [Full Text] [Related]
13. In-vitro effect of oncostatin M on the release by endothelial cells of von Willebrand factor, tissue-type plasminogen activator and plasminogen activator inhibitor-1. Pourtau J; Soria C; Paysant J; Vannier JP; Vasse M Blood Coagul Fibrinolysis; 1998 Oct; 9(7):609-15. PubMed ID: 9863709 [TBL] [Abstract][Full Text] [Related]
14. Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products. Emeis JJ Ann N Y Acad Sci; 1992 Dec; 667():249-58. PubMed ID: 1309043 [No Abstract] [Full Text] [Related]
15. Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator inhibitor-1 from human endothelial cells. Santell L; Levin EG J Biol Chem; 1988 Nov; 263(32):16802-8. PubMed ID: 2460455 [TBL] [Abstract][Full Text] [Related]